scPharmaceuticals Inc.
Hedge Funds Holdings
Last updated:
scPharmaceuticals Inc.‘s stocks are currently a part of 34 hedge funds’ portfolios, which represents 58.07% of the total amount of its stocks outstanding. This makes up a total of 15.88M shares of scPharmaceuticals Inc.. Compared to the previous quarter, the number fell by -0.33% or -53.13K shares fewer. As for the holding position changes, 20.59% (7) of current hedge fund investors increased the number of shares held, 32.35% (11) of current holders sold a part of the shares held, and 5.88% (2) closed the holdings completely. 6 hedge funds are new holders of scPharmaceuticals Inc. stock in Q1 2022, it is 17.65% of total holders.
Hedge funds holding scPharmaceuticals (Q4 2017 – Q1 2022)
| Q4 2017 | 24 |
|---|---|
| Q1 2018 | 38 |
| Q2 2018 | 39 |
| Q3 2018 | 32 |
| Q4 2018 | 34 |
| Q1 2019 | 32 |
| Q2 2019 | 28 |
| Q3 2019 | 25 |
| Q4 2019 | 27 |
| Q1 2020 | 32 |
| Q2 2020 | 51 |
| Q3 2020 | 50 |
| Q4 2020 | 46 |
| Q1 2021 | 45 |
| Q2 2021 | 35 |
| Q3 2021 | 30 |
| Q4 2021 | 30 |
| Q1 2022 | 34 |
Hedge funds changes in scPharmaceuticals positions (Q4 2017 – Q1 2022)
| Q4 2017 | 24 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2018 | 22 | 8 | 4 | 8 | -4 |
| Q2 2018 | 12 | 14 | 5 | 11 | -3 |
| Q3 2018 | 1 | 14 | 6 | 8 | 3 |
| Q4 2018 | 4 | 8 | 12 | 2 | 8 |
| Q1 2019 | 3 | 7 | 13 | 5 | 4 |
| Q2 2019 | 7 | 6 | 12 | 11 | -8 |
| Q3 2019 | 6 | 6 | 7 | 9 | -3 |
| Q4 2019 | 10 | 5 | 5 | 8 | -1 |
| Q1 2020 | 12 | 8 | 7 | 6 | -1 |
| Q2 2020 | 24 | 19 | 6 | 5 | -3 |
| Q3 2020 | 5 | 17 | 17 | 6 | 5 |
| Q4 2020 | 8 | 16 | 13 | 12 | -3 |
| Q1 2021 | 3 | 17 | 14 | 4 | 7 |
| Q2 2021 | 5 | 4 | 21 | 15 | -10 |
| Q3 2021 | 2 | 12 | 11 | 7 | -2 |
| Q4 2021 | 4 | 10 | 8 | 4 | 4 |
| Q1 2022 | 6 | 7 | 11 | 2 | 8 |
Hedge funds changes in scPharmaceuticals stock options (Q4 2017 – Q1 2022)
| Q4 2017 | 0 | 0 |
|---|---|---|
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 18,000 | 0 |
| Q3 2021 | 21,000 | 0 |
| Q4 2021 | 2,000 | 0 |
| Q1 2022 | 0 | 0 |